Mphasis Ltd Q3 FY26 Earnings Analysis

Published 16 Aug 2026 | IT - Software | Market Cap: ₹47.0K Cr

Price

2,545

Market Cap

₹47.0K Cr

P/E Ratio

24.3

Earnings Summary

FY26 is expected to be better than FY25 despite headwinds, providing confidence for FY27 growth. Mphasis expects growth momentum to continue driven by strong deal wins and pipeline conversion, especially in AI-led modernization.

📊 Revenue & Sales Performance

  • FY26 is expected to be better than FY25 despite headwinds, providing confidence for FY27 growth.
  • Growth model and framework indicate direct business trending toward double-digit growth in Q3, setting a template for future growth.
  • Strong deal wins and pipeline, with net new TCV wins at $428Mn and an LTM TCV of $2.1Bn, support sustained growth momentum.
  • AI-led pipeline has grown 66% YoY, comprising 69% of total pipeline; BFS pipeline up 98% YoY, and large deal pipeline up 91% YoY.
  • Anticipate continued ramp-up and conversion of large deals, with Q4 likely being the strongest sequential growth quarter for FY26.
  • BFS and Insurance verticals showing robust sequential and YoY growth, contributing significantly to revenue.
  • Pipeline and deal wins expected to maintain growth, with potential for acceleration when transformation deals ramp up fully.
  • More detailed FY27 growth outlook to be provided in April call when visibility improves.

📈 Profitability & Margins

  • Mphasis expects growth momentum to continue driven by strong deal wins and pipeline conversion, especially in AI-led modernization.
  • They are maintaining EBIT margin guidance within 14.75% to 15.75%, reflecting margin discipline while investing for growth.
  • Operating profit grew 11.6% YoY and EPS grew 9% YoY excluding exceptional items in Q3FY26.
  • The company anticipates FY26 to be better than FY25 and expects the growth template seen in the last few quarters to continue into FY27.
  • Q4FY26 is expected to be the strongest sequential growth quarter due to ramp-up of deals and recovery from furloughs.
  • They foresee potential operating leverage and margin expansion from AI infusion in deals, though it's still early to see this uniformly.
  • Sustained double-digit direct business growth and pipeline growth (>60% YoY) support this outlook.

🏗️ Capital Expenditure Plans

  • Mphasis is investing in AI platforms centered on orchestrating multiple third-party systems, integrating large language models (LLMs), proprietary solutions, and third-party assets.
  • A significant portion of this AI platform development runs through operating expenses (OpEx), while some investments, such as third-party platform integrations, are capitalized.
  • Between March 2025 and December 2025, there was noticeable growth in intangibles under development (related to AI platform launch) and other assets due to investments and upfront payments in large deals.
  • There have been capital expenditures (CapEx) related to platform development, with portions already paid out and some ongoing.
  • Mphasis is focused on building an ecosystem of tech providers, cloud providers, and infrastructure transformation partners to tap into modernization opportunities, indicating strategic investments in partnerships and capabilities.
  • Overall, investments are aimed at supporting the AI-first, NeoIP platform strategy driving future growth.

💰 Fundraising & Capital Structure

  • There is no explicit mention of any current or planned new fundraising through debt or equity in the latest updates.
  • Debt levels have increased in the past four quarters, primarily due to acquisition-related payouts and temporary financing needs across geographies.
  • The company uses short-term borrowing strategically to manage cash flow mismatches between geographies, specifically to avoid unfavorable interest rate arbitrage.
  • No indication of a trend towards increasing debt was noted; borrowing levels fluctuate up and down based on operational needs.
  • Dividend payments and acquisition-related cash outflows have impacted cash balances.
  • Future funding plans are not detailed, suggesting no imminent or large-scale new debt/equity fundraising announced as of January 2026.

📋 Order Book & Pipeline

  • The pipeline has grown 66% YoY, with 69% of it being AI-led.
  • BFS pipeline is up 98% YoY, non-BFS pipeline up 44% YoY.
  • Large deal pipeline is up 91% YoY.
  • Net new TCV wins for the quarter were $428 million.
  • LTM TCV has doubled to $2.1 billion.
  • Strong conversion of TCV to revenue has been maintained.
  • Four large deals won in Q3, including two deals over $50 million.
  • The deal pipeline continues to provide visibility for sustaining momentum in deal wins.

Key Metrics

Frequently Asked Questions

What were Mphasis Ltd Q3 FY26 results?

FY26 is expected to be better than FY25 despite headwinds, providing confidence for FY27 growth. Mphasis expects growth momentum to continue driven by strong deal wins and pipeline conversion, especially in AI-led modernization.

What is Mphasis Ltd share price analysis?

Mphasis Ltd currently shows a neutral. The stock trades at a P/E of 24.2 with a market cap of ₹46,956 Cr. Investors should review the full earnings analysis for detailed insights.

Is Mphasis Ltd planning capital expenditure?

Mphasis is investing in AI platforms centered on orchestrating multiple third-party systems, integrating large language models (LLMs), proprietary solutions, and third-party assets.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.

What Mphasis Ltd's management said in earlier quarters

Others in IT - Software this season

  • Coforge Ltd (Q3 FY26)

    The signed order book for the next 12 months is 30% higher than a year ago, indicating strong executable revenue. Coforge Ltd Q3 FY26 results — Market Cap…

  • C.E. Info Systems Ltd (Q3 FY26)

    Government business forms around 20% of revenues, with central government-funded schemes making up 90% of that; execution challenges at state levels may…

  • Fractal Analytics Ltd (Q3 FY26)

    Recent growth drivers include strong expansion in healthcare and life sciences (78% YoY growth) and banking/financial services (26% YoY growth). Fractal…

  • Capillary Technologies India Ltd (Q3 FY26)

    Revenue grew 16% year-on-year in Q3 FY26, with 22% growth for the nine months period. Capillary Technologies India Ltd Q3 FY26 results — Market Cap ₹4,587…